1. Immunology/Inflammation NF-κB Metabolic Enzyme/Protease Apoptosis
  2. Reactive Oxygen Species (ROS) Endogenous Metabolite Apoptosis
  3. Zinc Protoporphyrin

Zinc Protoporphyrin  (Synonyms: Zn(II)-protoporphyrin IX; ZnPP; Zinc Protoporphyrin-9)

Cat. No.: HY-101193 Pureté: 99.87%
Instruction de manipulation Technical Support

Zinc Protoporphyrin (Zn(II)-protoporphyrin IX) is an orally active and competitive heme oxygenase-1 (HO-1) inhibitor. Zinc Protoporphyrin regulates expression of HO-1 at the transcriptional level. The effect of Zinc Protoporphyrin on HO-1 expression is controversial.  It was shown to induce HO-1 expression in some cells, but suppress it in others. Zinc Protoporphyrin is used as a screening marker of iron deficiency in vivo. Zinc Protoporphyrin has anti-cancer activity.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

CAS No. : 15442-64-5

Size Prix Stock Quantité
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
En stock
Solution
10 mM * 1 mL in DMSO En stock
Solid
5 mg En stock
10 mg En stock
25 mg En stock
50 mg En stock
100 mg En stock
200 mg   Obtenir un devis  
500 mg   Obtenir un devis  

* Veuillez sélectionner la quantité avant d'ajouter des articles.

This product is a controlled substance and not for sale in your territory.

Avis client

Based on 67 publication(s) in Google Scholar

Other Forms of Zinc Protoporphyrin:

Top Publications Citing Use of Products

67 Publications Citing Use of MCE Zinc Protoporphyrin

Cell Proliferation/Viability Assay
Flow Cytometry
WB
Cell Imaging/Staining
Histological Imaging/Staining
In Vivo Efficacy Study

    Zinc Protoporphyrin purchased from MedChemExpress. Usage Cited in: Bone Res. 2025 Jan 16;13(1):9.  [Abstract]

    MLO-Y4 cell viability after 48 h treatment with 75% B16F10 CM, with or without 24 h pretreatment with 10 μmol/L Fer-1, Znpp, or DMSO (control).

    Zinc Protoporphyrin purchased from MedChemExpress. Usage Cited in: Bone Res. 2025 Jan 16;13(1):9.  [Abstract]

    FACS analysis using C11 BODIPY 581/591 and H2DCFDA to quantify ferroptosis in MLO-Y4 cells after 48 h treatment with 75% B16F10 CM, with or without 24 h pretreatment with 10 μmol/L Fer-1, Znpp, or DMSO (control).

    Zinc Protoporphyrin purchased from MedChemExpress. Usage Cited in: Bone Res. 2025 Jan 16;13(1):9.  [Abstract]

    Western blot of MLO-Y4 cells after 48 h treatment with 75% B16F10 CM, with or without 24 h pretreatment with 10 μmol/L Znpp, or DMSO (control).

    Zinc Protoporphyrin purchased from MedChemExpress. Usage Cited in: Bone Res. 2025 Jan 16;13(1):9.  [Abstract]

    Transmission electron microscopy (TEM) of MLO-Y4 cells after 48 h treatment with 75% B16F10 CM, with or without 24 h pretreatment with 10 μmol/L Znpp, or DMSO (control). Scale bars: 2500 nm (left), 1000 nm (right).

    Zinc Protoporphyrin purchased from MedChemExpress. Usage Cited in: Bone Res. 2025 Jan 16;13(1):9.  [Abstract]

    H&E staining of cortical bones from mice injected with B16F10 and treated with DMSO, 1 mg/kg Fer-1, or 10 mg/kg Znpp (i.p., 13 d).

    Zinc Protoporphyrin purchased from MedChemExpress. Usage Cited in: Bone Res. 2025 Jan 16;13(1):9.  [Abstract]

    µCT analysis of trabecular bone from mice injected with B16F10 and treated with DMSO, 1 mg/kg Fer-1, or 10 mg/kg Znpp (i.p., 13 d).

    Voir tous les produits spécifiques à Isoform Endogenous Metabolite:

    • Activité biologique

    • Pureté et documentation

    • Références

    • Avis client

    Description

    Zinc Protoporphyrin (Zn(II)-protoporphyrin IX) is an orally active and competitive heme oxygenase-1 (HO-1) inhibitor. Zinc Protoporphyrin regulates expression of HO-1 at the transcriptional level. The effect of Zinc Protoporphyrin on HO-1 expression is controversial.  It was shown to induce HO-1 expression in some cells, but suppress it in others. Zinc Protoporphyrin is used as a screening marker of iron deficiency in vivo. Zinc Protoporphyrin has anti-cancer activity[1][2][3][4][5].

    IC50 & Target[1][2]

    Human Endogenous Metabolite

     

    In Vitro

    to increase in Protoporphyrin (Zn(II)-protoporphyrin IX; 5 μM; 72 hours) causes the fraction of late apoptotic and necrotic cells increasing from 10.9% in controls to 30.4% after 72 h[3].
    Zinc Protoporphyrin (1.25-40 μM; 48 or 72 hours) exerts cytostatic/cytotoxic effects against tumor cells[3].
    Zinc Protoporphyrin (2.5, 5 μM; 48 or 72 hours) results in dose- and time-dependent reduction of cells in the G1 phase of the cell cycle[3].
    Zinc Protoporphyrin (1.25-40 μM; 48 hours) leads to the accumulation of cleaved (active) caspase-3[3].
    The effect of Zinc Protoporphyrin on HO-1 expression is controversial.  It was shown to induce HO-1 expression in some cells, but suppress it in others[4][5].
    For example, Zinc Protoporphyrin is shown to induce HO-1 expression in hamster fibroblast (HA-1) cells but not in Neuro-2A mouse neuroblastoma cells and primary cultures of rat cortical neurons.
    Zinc Protoporphyrin suppresses the induction of HO-1 by statins or lipopolysaccharide.
    Zinc Protoporphyrin induces HO-1 expression in human prostate adenocarcinoma PC-3 and breast adenocarcinoma MCF-7 cells.

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Apoptosis Analysis[3]

    Cell Line: C-26 cells
    Concentration: 5 μM
    Incubation Time: 72 hours
    Result: The fraction of late apoptotic and necrotic cells increased from 10.9% in controls to 30.4% after 72 h.

    Cell Cytotoxicity Assay[3]

    Cell Line: C-26 and MDA-MB231 cells
    Concentration: 1.25, 2.5, 5, 10, 20, 40 μM
    Incubation Time: 48 or 72 hours
    Result: Exerted cystostatic/cytotoxic effects against tumor cells.

    Cell Cycle Analysis[3]

    Cell Line: C-26 cells
    Concentration: 2.5, 5 μM
    Incubation Time: 48 or 72 hours
    Result: Resulted in dose- and time-dependent reduction of cells in G1 phase of the cell cycle.

    Western Blot Analysis[3]

    Cell Line: C-26 cells
    Concentration: 1.25, 2.5, 5, 10, 20, 40 μM
    Incubation Time: 48 hours
    Result: Leaded to accumulation of cleaved (active) caspase-3.
    In Vivo

    Zinc Protoporphyrin (12.5, 25, 50 mg/kg for i.p.; 12.5, 50 mg/kg for p.o.; from day 7 to 19) exerts dose-dependent antitumor effects manifested by the retardation of tumor growth[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: BALB/c mice inoculated with C-26 cells[3]
    Dosage: 12.5, 25, 50 mg/kg for i.p.; 12.5, 50 mg/kg for p.o.
    Administration: IP or PO; from day 7 to 19
    Result: Exerted dose-dependent antitumor effects manifested by the retardation of tumor growth.
    Essai clinique
    Masse moléculaire

    626.02

    Formule

    C34H32N4O4Zn

    CAS No.
    Appearance

    Solid

    Color

    Brown to black

    SMILES

    OC(CCC1=C(C=C2[N]3=C4C(C)=C2CCC(O)=O)[N-]([Zn+2]35[N]6=C7C=C(C(C=C)=C8C)[N-]5C8=C4)C(C=C6C(C=C)=C7C)=C1C)=O

    Structure Classification
    Initial Source
    Livraison

    Room temperature in continental US; may vary elsewhere.

    Stockage

    -20°C, sealed storage, away from moisture

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

    Solvant et solubilité
    In Vitro: 

    DMSO : 20.59 mg/mL (32.89 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.5974 mL 7.9870 mL 15.9739 mL
    5 mM 0.3195 mL 1.5974 mL 3.1948 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Calculateur de molarité

    • Calculateur de dilution

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  50% PEG300    50% Saline

      Solubility: 1.67 mg/mL (2.67 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    Pureté et documentation

    Purity: 99.87%

    Références

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 1.5974 mL 7.9870 mL 15.9739 mL 39.9348 mL
    5 mM 0.3195 mL 1.5974 mL 3.1948 mL 7.9870 mL
    10 mM 0.1597 mL 0.7987 mL 1.5974 mL 3.9935 mL
    15 mM 0.1065 mL 0.5325 mL 1.0649 mL 2.6623 mL
    20 mM 0.0799 mL 0.3993 mL 0.7987 mL 1.9967 mL
    25 mM 0.0639 mL 0.3195 mL 0.6390 mL 1.5974 mL
    30 mM 0.0532 mL 0.2662 mL 0.5325 mL 1.3312 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Vos produits récemment consultés:

    Demande en ligne

    Your information is safe with us. * Required Fields.

    Nom du produit

     

    Requested Quantity *

    Nom du demandeur *

     

    Civilité

    Adresse e-mail *

     

    Numéro de téléphone *

    Department

     

    Nom de l'organisation *

    City

    État

    Country or Region *

         

    Remarques

    Bulk Inquiry

    Inquiry Information

    Nom du produit:
    Zinc Protoporphyrin
    Cat. No.:
    HY-101193
    Quantité:
    MCE Japan Authorized Agent: